Pancreatic Cancer Research

ResearcherWuhan UniversityActive in the last 2 years

Tian Xia

Matched on ORCID iD 0000-0003-0733-0697; OpenAlex author ID A5101889108. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 3 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 8

  1. ILF3 mediates lipid metabolism to promote pancreatic cancer development by regulating CPT1A-activated PPARa signaling pathway. Co-author DOI 10.1016/j.bbadis.2025.167919↗
  2. Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regul… Last author DOI 10.1002/ctm2.1799↗
  3. Erratum: miR-455-3p Functions as a Tumor Suppressor by Restraining Wnt/β-Catenin Signaling via TAZ in Pancreatic Cancer [Corrigendum]. Co-author DOI 10.2147/cmar.s387344↗
  4. miR-324-5p Contributes to Cell Proliferation and Apoptosis in Pancreatic Cancer by Targeting KLF3. Co-author DOI 10.1016/j.omto.2020.07.011↗
  5. MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/β-Catenin Signal via ST7L. Co-author DOI 10.1177/1533033820945801↗
  6. miR-455-3p Functions as a Tumor Suppressor by Restraining Wnt/β-Catenin Signaling via TAZ in Pancreatic Cancer. Co-author DOI 10.2147/cmar.s235794↗
  7. Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ. Co-author DOI 10.1016/j.omtn.2017.12.002↗
  8. miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer. Co-author DOI 10.1093/carcin/bgy074↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaodong Huang · 8 shared papers, 2018–2025 · strength 1.03
  2. Ting Zhan · 8 shared papers, 2018–2025 · strength 1.03
  3. Xiaoli Chen · 5 shared papers, 2018–2020 · strength 0.47
  4. Yu Ding · 2 shared papers, 2018–2020 · strength 0.19
  5. Yi-Yuan Wan · 2 shared papers, 2018–2020 · strength 0.18
  6. Wei Chen · 1 shared paper, 2022 · strength 0.14
  7. Zheng Han · 1 shared paper, 2022 · strength 0.14
  8. Yadong Zhang · 1 shared paper, 2020 · strength 0.10
  9. Yadong Zhang · 1 shared paper, 2018 · strength 0.09
  10. Zhongxin Lu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.